HR and breast cancer: Most participants resided in Mexico (90.30%), completed at least post‐secondary education (64%), were currently employed (45%), had been diagnosed with early‐stage breast cancer (stages 0–IIIA: 86%), and were classified as HR+/HER2− disease (66%).